TVARDI THERAPEUTICS, INC. Income Taxes Receivable, Current
TVARDI THERAPEUTICS, INC. (TVRD) had Income Taxes Receivable, Current of $697.00 thousand as of 2024-06-30, per its 10-Q filed 2024-08-14.
Financial Statements › Notes › Nontrade Receivables › Nontrade Receivables, Current
us-gaap:IncomeTaxesReceivable · last filed 2025-03-11
- 2024-06-30: Income Taxes Receivable, Current $697.00K.
- 2024-03-31: Income Taxes Receivable, Current $697.00K.
- 2023-12-31: Income Taxes Receivable, Current $697.00K.
- 2023-09-30: Income Taxes Receivable, Current $697.00K.
| Period end | Income Taxes Receivable, Current |
|---|---|
| 2024-06-30 | $697.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $697.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $697.00K 10-K · filed 2025-03-11 |
| 2023-09-30 | $697.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $697.00K 10-Q · filed 2023-08-07 |
| 2023-03-31 | $697.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $697.00K 10-K · filed 2024-03-06 |
| 2022-09-30 | $697.00K 10-Q · filed 2022-11-07 |
| 2022-06-30 | $697.00K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $697.00K 10-Q · filed 2022-05-09 |
| 2021-12-31 | $697.00K 10-K · filed 2023-03-06 |
| 2021-09-30 | $697.00K 10-Q · filed 2021-11-08 |
| 2021-06-30 | $697.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $1.51M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $1.51M 10-K · filed 2022-03-01 |
| 2020-09-30 | $1.25M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $1.12M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $938.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $816.00K 10-K · filed 2021-02-25 |
| 2019-09-30 | $1.03M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $984.00K 10-Q · filed 2019-08-07 |
| 2019-03-31 | $749.00K 10-Q · filed 2019-05-07 |
| 2018-12-31 | $664.00K 10-K · filed 2020-02-27 |
| 2018-09-30 | $539.00K 10-Q · filed 2018-11-06 |
| 2018-06-30 | $473.00K 10-Q · filed 2018-08-07 |
| 2018-03-31 | $777.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | $731.00K 10-K · filed 2019-03-12 |
| 2017-09-30 | $705.00K 10-Q · filed 2017-11-02 |
| 2017-06-30 | $560.00K 10-Q · filed 2017-08-03 |
| 2017-03-31 | $558.00K 10-Q · filed 2017-05-04 |
| 2016-12-31 | $852.00K 10-K · filed 2018-03-15 |
| 2016-09-30 | $663.00K 10-Q · filed 2016-11-04 |
| 2016-06-30 | $608.00K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $529.00K 10-Q · filed 2016-05-05 |
| 2015-12-31 | $384.00K 10-K · filed 2017-03-10 |
| 2015-09-30 | $450.00K 10-Q · filed 2015-11-09 |
| 2015-06-30 | $250.00K 10-Q · filed 2015-08-10 |
| 2015-03-31 | $215.00K 10-Q · filed 2015-05-12 |
| 2014-12-31 | $200.00K 10-K · filed 2016-03-11 |
| 2014-09-30 | $89.00K 10-Q · filed 2014-11-10 |
| 2014-06-30 | $57.00K 10-Q · filed 2014-08-07 |
| 2014-03-31 | $46.00K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $61.00K 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |